Amarin | AMRN - Ticaret Borçlular





Ticaret Borçlular Değişiklik Tarih
AbbVie USD 12.59B 180M 2025-12
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
Amarin USD 126.83M 477K 2025-12
AstraZeneca USD 17.88B 1.17B 2026-03
BioCryst Pharmaceuticals USD 106.82M 15.49M 2025-12
DBV Technologies USD 15.97M 279K 2025-09
Esperion Therapeutics USD 140.19M 21.21M 2025-12
GlaxoSmithKline GBP 7.94B 178M 2026-03
Halozyme Therapeutics USD 441.27M 95.24M 2025-12
Heron Therapeutics USD 89.59M 8.54M 2025-12
Ionis Pharmaceuticals USD 74M 8M 2026-03
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
Novartis USD 12.29B 3.3B 2025-12